Brief: Glaukos Q3 Sales USD 96.7 Million Vs. IBES Estimate USD 91.5 Million
04/11/2024 21:05
Nov 04 (Reuters) - Glaukos Q3 adjusted net income USD -15.2 million vs. IBES estimate USD -25 million. * Q3 net income USD -21.4 million * Q3 gross margin 77% * Q3 adjusted gross margin 82% * outlook FY sales USD 377-379 million
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary